Drug intelligence / Profile preview

amoxicillin + ampicillin

Development stage
Unknown
Lead developer
US Antibiotics
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Amoxicillin + ampicillin is a combination of two beta-lactam antibiotics from the penicillin class. Both drugs act by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins, leading to cell lysis and death. Amoxicillin and ampicillin have overlapping but distinct spectra of activity against gram-positive and some gram-negative bacteria. This combination is not a standard or widely marketed formulation; both are typically used individually or in other combinations (e.g., with beta-lactamase inhibitors). The primary indications for each include treatment of infections such as those affecting the respiratory tract, urinary tract, skin, gastrointestinal system, and certain sexually transmitted infections[3][4][9][10]. There is no evidence that this specific combination (amoxicillin + ampicillin) is approved or commonly used as a fixed-dose product.

02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on amoxicillin + ampicillin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amoxicillin + ampicillin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call